Sanofi KSA marks 5th anniversary of factory in KAEC

The ceremony, which was held at the factory facility, was attended by members of Sanofi management, representing the parent company, in addition to Dr. Ahmed Serag, general manager of Sanofi Saudi Arabia.
Short Url
Updated 19 January 2020

Sanofi KSA marks 5th anniversary of factory in KAEC

Health care company Sanofi Saudi Arabia recently hosted a celebration marking the fifth anniversary of launching its pharmaceutical production plant in the Industrial Valley of King Abdullah Economic City (KAEC) in Jeddah. The ceremony, which was held at the factory facility, was attended by members of Sanofi management, representing the parent company, in addition to Dr. Ahmed Serag, general manager of Sanofi Saudi Arabia.

Dr. Serag said: “Since the factory was launched five years ago where we started to produce medicines locally, Sanofi factory will always be remembered as a success story that the company is proud of. The ambition and determination of Sanofi team steered the company to create a brilliant brand that loomed in the sky of pharmaceutical manufacturing and became a leader in the provision of reliable treatment solutions at the domestic level. 

“During the five years since the factory was set up, the work team was laser-focused on achieving excellence in services through a broad understanding of the Kingdom’s Vision 2030 that placed among its aims the promotion of pharmaceutical manufacturing in the Kingdom. The presence of the factory in KAEC is of particular importance, as it not only targets the Saudi market, but the entire Middle East region.”

Recently, Sanofi obtained an authorization from the Saudi Food and Drug Authority to manufacture the first drug that exclusively bears Sanofi’s name and trademark, a drug that is classified under the category of antibiotics and is used in the treatment of different groups of bacterial infections.

The company aims to increase the number of Saudis within the total workforce in the factory, providing Saudi youth an opportunity to qualify for a scientific career. The factory covers a total area of ​​35,000 square meters and was designed to locally produce up to 20 million packs of high-quality medicines that meet the needs of the regional community. The factory’s products cover the treatment of diabetes, cardiovascular disease, pain, tumors, cholesterol, and nervous system management drugs, as well as anticoagulants, antibiotics, antihistamines and antacids.


Ford works with 3M, GE in fight against COVID-19

Ford Motor Company’s US design team is quickly creating and starting to test transparent full-face shields for medical workers and first responders.
Updated 31 March 2020

Ford works with 3M, GE in fight against COVID-19

Ford Motor Company, joining forces with firms including 3M and GE Healthcare, is lending its manufacturing and engineering expertise to quickly expand production of urgently needed medical equipment and supplies for health care workers, first responders and patients fighting coronavirus.
In addition, Ford plans to assemble more than 100,000 face shields per week and leverage its in-house 3D printing capability to produce components for use in personal protective equipment.
“This is such a critical time for America and the world. It is a time for action and cooperation. By coming together across multiple industries, we can make a real difference for people in need and for those on the front lines of this crisis,” said Bill Ford, Ford’s executive chairman.
Ford team members are working with 3M to increase the manufacturing capacity of their powered air-purifying respirator (PAPR) designs and working jointly to develop a new design leveraging parts from both companies to meet the surge demand for first responders and health care workers. This new respirator could be produced in a Ford facility by UAW workers.
To go as fast as possible, the Ford and 3M teams have been resourcefully locating off-the-shelf parts like fans from the Ford F-150’s cooled seats for airflow, 3M HEPA air filters to filter airborne contaminants such as droplets that carry virus particles and portable tool battery packs to power these respirators for up to eight hours.

HIGHLIGHTS

• Ford is working with 3M to manufacture at scale powered air-purifying respirators (PAPRs).

• Ford and GE Healthcare are working to produce a simplified version of GE Healthcare’s existing ventilator design.

• Ford, in cooperation with the UAW, will assemble more than 100,000 plastic face shields per week at a Ford manufacturing site.

“Working with 3M and GE, we have empowered our teams of engineers and designers to be scrappy and creative to quickly help scale up production of this vital equipment,” said Jim Hackett, Ford’s president and CEO. “We are focusing our efforts to help increase the supply of respirators, face shields and ventilators that can help assist health care workers, first responders, critical workers as well as those who have been infected by the virus.”
“We’re exploring all available opportunities to further expand 3M’s capacity and get health care supplies as quickly as possible to where they’re needed most — which includes partnering with other great companies like Ford,” said Mike Roman, 3M chairman of the board and chief executive officer.
In addition, Ford and GE Healthcare are working together to expand production of a simplified version of GE Healthcare’s existing ventilator design to support patients with respiratory failure or difficulty breathing caused by COVID-19. These ventilators could be produced at a Ford manufacturing site in addition to a GE location.  
“We are encouraged by how quickly companies from across industries have mobilized to address the growing challenge we collectively face from COVID-19,” said GE Healthcare President and CEO Kieran Murphy.
Meanwhile, Ford’s US design team also is quickly creating and starting to test transparent full-face shields for medical workers and first responders.